The average frequency and absolute number of CD19+CD24+CD38+ B cells in the PD-L1hi BC group were higher than those in the PD-L1lo BC group under IDR conditions (P = 0.008, P = 0.007, respectively; Figure 5B). This evidence concerns the gene CD19 and breast cancer.